High materiality8/10
Roivant Sciences (ROIV) PT Raised to $46 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises Roivant Sciences target to $46; price $41.48.
- Guggenheim raises ROIV target to $46; price $41.48.
Key facts
- 01
Target: $46
- 02
Posted price: $41.48
- 03
Analyst firm: Guggenheim
- 04
Analyst: Yastin Suneja
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.